The recommended values of eGFR and ACR for use of dapagliflozin in people without type 2 diabetes relate to the parameters of the population enrolled in the DAPA-CKD trial
[1] Alcohol use disorder : Heavy alcohol consumption is a major pancreatitis risk factor and may compound any medication-related risk
A good metric to consider is this: If an obese patient (BMI 30 to 34.9) is on a GLP-1 for six months and has not reached 10% TBWL, they should be referred back to their primary care provider to reassess their weight-loss plan
The price gap is real, but it reflects the cost of manufacturing standards, testing, medical oversight, and regulatory compliance
Hamilos DL, Zelarney P, Mascali JJ
Different doses allow your healthcare provider to titrate your treatment plan based on how your body responds and your individual tolerance